Hepatitis C Recent News
Why Johnson & Johnson's Strong Pharmaceutical Business Is A Concern
Health Care And Biotech Sector Looking Sick
CNBC's Meg Tirrell Breaks Down The AbbVie/Express Scripts Deal
Exclusive: Enanta Pharmaceuticals CEO Jay Luly Discusses Hep C Pipeline
Advances In HIV, Hep C Treatments Could Spark Renewed Interest In Biotech Stocks
Takeover Whispers Add To Achillion Pharmaceuticals' Momentum
Hepatitis C Stocks Move After Idenix Rockets Up 235%
How Did Analysts Get Gilead's Earnings Completely Wrong?
Market Wrap For January 8: Fed Minutes Released
Possible Hepatitis C Outbreak Could Lift This ETF